GlassScriptPhysician profile
Barbara J Thompson
NPI 1336425032
$5,283.13
in general payments reported to CMS, 2019-2025
19 companies · $888 in 2025
The $888 reported for 2025 was more than what 83% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $302 · 2022: $2,710 · 2023: $840 · 2024: $543 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,253 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,252.91 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,696.06 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $1,186.23 | 2021-2025 | Farapulse, Rhythmia Mapping System, Watchman Access System |
| Impulse Dynamics (USA) INC. | $306.19 | 2022 | |
| Sanofi-Aventis U.S. LLC | $190.04 | 2021-2023 | |
| Amgen INC. | $120.38 | 2021-2024 | Repatha |
| Merck Sharp & Dohme LLC | $112.22 | 2022-2025 | Verquvo |
| Novo Nordisk INC | $111.62 | 2023-2025 | Wegovy, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $79.45 | 2022-2023 | Camzyos |
| Pfizer INC. | $79.25 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $76.22 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $63.13 | 2022-2024 | Farxiga |
| Alnylam Pharmaceuticals INC. | $59.32 | 2024-2025 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.70 | 2022-2025 | Lifevest |
| Atricure, INC. | $45.15 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Kiniksa Pharmaceuticals International, Plc | $37.00 | 2024 | Arcalyst |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $19.81 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $17.68 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.24 | 2024 | Jardiance |
| Biogen, INC. | $13.44 | 2024 | Skyclarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.